While on the other hand, the treatment group of the cancer tissue with PFT-HSA-TFT-Cy7 and PFT-Hcy-HSA-Cy7 shows a significant decrease in level of IFN-γ mRNA, with an average decrease in fold change as 3.3-fold and 3.2-fold at 1 μM and 3.0-fold and 1.7-fold at 3 μM concentration of nanoassemblies (Figure 6(a)). The gene discussed is TBXT; the disease is cancer.